4 studies found for: POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE
|1||Not yet recruiting||
A Safety, Pharmacokinetic, Single Ascending Dose Study of Tesevatinib in Pediatric Subjects With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
UAB Recessive PKD Research and Translational Core Center
|3||Active, not recruiting||
Clinical and Molecular Investigations Into Ciliopathies
UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
† Study has passed its completion date and status has not been verified in more than two years.